ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes

被引：399

作者：

Jensen, Robert T. ^{[1
]}

Cadiot, Guillaume ^{[2
]}

Brandi, Maria L. ^{[3
]}

de Herder, Wouter W. ^{[4
]}

Kaltsas, Gregory ^{[5
]}

Komminoth, Paul ^{[6
]}

Scoazec, Jean-Yves ^{[7
]}

Salazar, Ramon ^{[8
]}

Sauvanet, Alain ^{[7
]}

Kianmanesh, Reza ^{[9
]}

机构：

[1] NIH, Digest Dis Branch, Cell Biol Sect, Bethesda, MD 20892 USA

[2] CHU Reims, Hop Robert Debre, Serv Hepatogastroenterol, Reims, France

[3] Univ Florence, Florence, Italy

[4] Erasmus MC Univ, Dept Endocrinol, Rotterdam, Netherlands

[5] Natl Univ Athens, Dept Pathophysiol, Athens, Greece

[6] Stadtspital Triemli, Inst Pathol, Zurich, Switzerland

[7] Hop Edouard Herriot, Hosp Civils Lyon, Serv Cent Anat & Cytol Pathol, Lyon, France

[8] Inst Catala Oncol IDIBELL, Dept Oncol, Barcelona, Spain

[9] Louis Mourier Univ Hosp, Dept Surg, Colombes, France

来源：

NEUROENDOCRINOLOGY | 2012年 / 95卷 / 02期

关键词：

ZOLLINGER-ELLISON-SYNDROME; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; PROTON PUMP INHIBITORS; INSTITUTES-OF-HEALTH; LIVER METASTASES; SURGICAL-MANAGEMENT; CUSHINGS-SYNDROME; MEDICAL-TREATMENT; GASTROENTEROPANCREATIC TUMORS; PROGNOSTIC-FACTORS;

D O I：

10.1159/000335591

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：98 / 119

页数：22

共 225 条

[31] Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1
Cadiot, G
Vuagnat, A
Doukhan, I
Murat, A
Bonnaud, G
Delemer, B
Thiéfin, G
Beckers, A
Veyrac, M
Proye, C
Ruszniewski, P
Mignon, M
[J]. GASTROENTEROLOGY, 1999, 116 (02) : 286 - 293
[32] Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome
Cadiot, G
Houillier, P
Allouch, A
Paillard, M
Mignon, M
[J]. GUT, 1996, 39 (02) : 273 - 278
[33] Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy
Cadiot, G
Lebtahi, R
Sarda, L
Bonnaud, G
Marmuse, JP
Vissuzaine, C
Ruszniewski, P
LeGuludec, D
Mignon, M
[J]. GASTROENTEROLOGY, 1996, 111 (04) : 845 - 854
[34] Capelli P, 2009, ARCH PATHOL LAB MED, V133, P350, DOI 10.1043/1543-2165-133.3.350
[35] Pancreatic Endocrine Tumors Less Than 4 cm in Diameter Resect or Enucleate? A Single-Center Experience
Casadei, Riccardo
Ricci, Claudio
Rega, Daniela
D'Ambra, Marielda
Pezzilli, Raffaele
Tomassetti, Paola
Campana, Davide
Nori, Francesca
Minni, Francesco
[J]. PANCREAS, 2010, 39 (06) : 825 - 828
[36] Value of Both WHO and TNM Classification Systems for Patients with Pancreatic Endocrine Tumors: Results of a Single-Center Series
Casadei, Riccardo
Ricci, Claudio
Pezzilli, Raffaele
Campana, Davide
Tomassetti, Paola
Calculli, Lucia
Santini, Donatella
Antonacci, Nicola
Minni, Francesco
[J]. WORLD JOURNAL OF SURGERY, 2009, 33 (11) : 2458 - 2463
[37] Medical Treatment of Cushing's Syndrome: Glucocorticoid Receptor Antagonists and Mifepristone
Castinetti, Frederic
Conte-Devolx, Bernard
Brue, Thierry
[J]. NEUROENDOCRINOLOGY, 2010, 92 : 125 - 130
[38] Chetty R, 2008, ARCH PATHOL LAB MED, V132, P1285, DOI 10.1043/1543-2165(2008)132[1285:AOOPII]2.0.CO
[39] 2
[40] MULTIPLE HORMONE ELEVATIONS IN ZOLLINGER-ELLISON SYNDROME - PROSPECTIVE-STUDY OF CLINICAL-SIGNIFICANCE AND OF THE DEVELOPMENT OF A 2ND SYMPTOMATIC PANCREATIC ENDOCRINE TUMOR SYNDROME
CHIANG, HCV
ODORISIO, TM
HUANG, SC
MATON, PN
GARDNER, JD
JENSEN, RT
[J]. GASTROENTEROLOGY, 1990, 99 (06) : 1565 - 1575

← 1 2 3 4 5 6 7 8 9 10 →